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ABSTRACT 
Purpose 
There are two major methods of reprogramming: generation of induced pluripotent stem cells 
(iPSCs) by overexpressing embryonic-stem-cell-specific transcription factors (OCT4, SOX2, KLF4 
and c-MYC) and somatic cell nuclear transfer (SCNT) by oocyte-specific factors. Previously we 
reported oocyte-enriched histone variants TH2A, TH2B and the histone chaperone nucleoplasmin 
(NPM2) enhance the reprogramming by OSKM in mice. Mouse histone TH2A and TH2B form 
unstable nucleosome compared to canonical histones. In this study, I investigated the role of mouse 
histone TH2A and TH2B in modulating chromatin structure. Moreover I tested the role of human 
TH2A, TH2B and NPM2 in human induced pluripotent stem cell generation.  
Material and methods  
TH2A (HIST1H2AA, NM_170745.3) and TH2B (HIST1H2BA, NM_170610.2) were 
amplified from genomic DNA by PCR and inserted into pLenti6.3 vector. Expression of TH2A and 
TH2B were confirmed by western blot. Lentivirus system was used to generate induced pluripotent 
stem cells. After indicated time, live cell staining was performed with anti-SSEA4 and anti-TRA-1-60 
antibodies to count iPSC colonies. In vitro differentiation was performed by transferred iPSCs into 
non-adherent plate for 3 days prior to spontaneous differentiation in adherent plate. For teratoma 
formation, single iPSCs were transplanted into dorsal flanks of NOD/ShiJic-scidJcl mice. Teratomas 
were dissected after six to nine weeks and processed to hematoxylin and eosin staining or 
immunostaining with antibodies for three germ layers markers. Microarray analysis was performed by 
Human Gene 1.0 ST Array and processed by R package Oligo.  
Results   
 The nuclei from NIH3T3 cells expressing mouse TH2A, TH2B, and P-Npm exhibited 
higher DNase I sensitivity than those from cells overexpressing canonical histones. However 
these histone variants did not affect the total H3K9me3 level. Th2a-/-Th2b-/- spermatids have 
defects in the deposition of TNP2 on chromatin. The level of canonical histone H2B is 
upregulated by a feedback mechanism.  
Human TH2A, TH2B and NPM2 enhance the OSKM-induced reprogramming of human 
dermal fibroblasts and umbilical vein endothelial cells. Pluripotency of iPSCs generated by co-
expression OSKM and TH2A, TH2B, NPM2 was shown by in vitro and in vivo differentiation assays. 
These iPSCs gave rise to highly differentiated teratomas compared to iPSCs induced by OSKM alone. 
Genome-wide analysis showed that TH2A, TH2B and NPM2 regulated genes which are involved in 
naïve stem cell stage. Thus, TH2A, TH2B and NPM2 enhance reprogramming of human somatic cells 
and improve the quality of human iPSCs 
Discussion  
 Open chromatin is a hallmark of ESCs and iPSCs, in which the overall genome is 
hyperactive and the levels of heterochromatin are reduced compared with differentiated cells. 
The open chromatin state in ESCs is maintained by multiple chromatin remodeling factors, 
including Chd1 and the TIP60-p400 complex. Reduction of the Chd1 level in ESCs increased 
the amount of heterochromatin, whereas expression of TH2A/TH2B did not affect the level 
of H3K9me3, a typical marker of heterochromatin. These results suggest that TH2A/TH2B 
contribute to the reprogramming of somatic cells by inducing transcriptionally active open 
chromatin, whereas Chd1 contributes to the maintenance of an established open chromatin 
state in ESCs by suppressing heterochromatin formation.   
During the transition stage histone-to-protamine of spermiogenesis, multiple 
mechanisms may act in combination to destabilize the nucleosome and replace the histones. 
Hyperacetylation of canonical histones during spermatogenesis, especially H4, and multiple 
histone variants are thought to weaken DNA–histone octamers and nucleosome–nucleosome 
interactions. Nucleosomes containing hyperacetylated histones are thought to be more prone 
to displacement by protamines. These previous reports are consistent with the observations 
that mouse TH2A/TH2B, which induce an open chromatin structure, are required for the 
replacement of histones by TNPs.  
The effect of BAN is depend on the cell type of origin. BAN can enhance the number of 
TRA-1-60 and SSEA-4 positive colony number in HUVECs about 8 fold and 3.5 fold respectively. 
On the other hand, the degree of enhancement for adult dermal fibroblast is approximately 2.5 fold. 
During the reprogramming process, chromatin is reorganized and open chromatin structure is formed. 
HUVECs may efficiently form open chromatin than adult fibroblasts. BAN-regulated genes are 
overlapped with transcript signature of naïve human ESCs. Open chromatin structure induced by 
BAN may facilitate the naïve state of human ESCs or iPSCs. Indeed Ware et al. (2014) reported 
human ES cell lines in the later primed state can be toggled in reverse to naïve by exposure to histone 
deacetylase inhibitors prior to naïve culture. Naïve state cells are showed to have a high cellular 
potency due to the genome wide low methylation levels, and low expression of lineage specific genes, 
however mechanisms underlie the naïve state is still unclear and how BAN involve in this naïve state 
is an interesting topic for further research 
Conclusion  
In summary, TH2A and TH2B induce an open chromatin structure. The addition of TH2A, 
TH2B and P-NPM2 in the reprogramming cocktail may be a useful tool for generating clinical grade 
human iPSCs effectively.   
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CHAPTER 1. INTRODUCTION 
1.1 Overview of cellular potency 
The development starts from zygote, which has the highest cellular potency. Zygotes 
and early embryonic blastomeres up to four-cell embryonic stages are totipotent (Tarkowski 
et al., 1959) (Figure 1.1). These totipotent cells can differentiate into any cell types including 
embryonic and extraembryonic cell types. At the 16-cell stage, mouse embryonic blastomere 
separates into two lineages: the trophoblast lineage, which will develop to a part of placenta; 
and the inner cell mass (ICM) which gives rise to the epiblast and the hypoblast. The epiblast 
lineage cells will develop into the embryo, which consists of all the somatic cells and 
germline cells.  
Mouse embryonic stem cells (ESCs) (Evans and Kaufman, 1981; Martin, 1981) can 
be derived from expanding the ICM in vitro. These ESCs are pluripotent, they can form full 
embryo when aggregate with early blastomeres.  
After implantation into uterine wall, the late blastocyst converts into a cup-shaped 
structure known as egg cylinder (Kaufman, 1992). This egg cylinder is subjected to a 
systematic topological changes guided by growth factors from yolk sac and trophoblast cells 
(Beddington and Robertson, 1999). Transplantations of egg cylinders experiments indicate 
that they still can change fates (Gardner and Beddington, 1988). However, postimplantation 
epiblast stem cells can not contribute to embryo in chimera assay (Rossant, 2008). Therefore 
epiblast stem cells (EpiSCs) derived from post implantation blastocyst are primed pluripotent 
stem cells, which are primed to differentiate into specific cell types (Nichols et al., 2009).  
Human embryonic stem cells have been derived from human blastocysts (Thomson et 
al., 1998). However these human ESCs are significantly different from mouse ESCs in term 
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of morphology, differentiation capacity, transcriptional profiles and culture requirements. 
Human ESCs cannot contribute to embryo in chimera assays. The highest pluripotency test 
for human ESCs is based on teratoma formation, when they are injected into nude mice. Thus 
human ESCs are thought to be the analogous to mouse EpiSCs (Brons et al., 2007, Rossant, 
2008 and Tesar et al., 2007).  
Recent studies show that human ESCs can be converted into a naïve state, which is 
more similar to mouse ESCs, however still somewhat contradictory and controversial (Chan 
et al., 2013; Gafni et al., 2013; Takashima et al., 2014; Theunissen et al., 2014; Ware et al., 
2014). By using different modified culture medium or genetic modification by 
overexpressing key naïve transcription factors, the naïve hESCs transcriptional network is 
resetted to a more similar degree with their counterpart in early blastocysts stages. They also 
can contribute to chimera assay, exhibit low DNA methylation, and better differentiation 
capacity compared to primed ESCs.  
 
1.2 Reprogramming in early embryo  
Oocyte and sperm are one of the most highly specialized cells in the body. Upon 
fertilization, these gametes must undergo a drastic reconfiguration to form the zygote, which 
possesses the highest pluripotency. This remodeling involves both paternal and maternal 
genomes. In mammal, the oocyte is ovulated at the second meiotic metaphase and completes 
the meiosis when fertilization occurs, which results in the formation of a maternal pronucleus 
and a second polar body. On the other hand, the sperm genome is tightly packaged with 
nucleoprotamine, upon fertilization, the sperm nuclear envelope is broken down, protamines 
are exchanged with histones, then chromatin is decondensated and pronuclear is formed 
(Dean et al., 2003).  
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1.3 Induced pluripotent stem cells 
In 2006, Takahashi and Yamanaka successfully convert mouse somatic fibroblasts 
into induced pluripotent stem cells (iPSCs) by overexpressing four transcription factors: Oct4, 
Sox2, Klf4, and c-Myc (Takahashi, 2006). These iPSCs can contribute to both somatic and 
germline in chimeric mice (Okita et al., 2007 and Wernig et al., 2007), which are the 
hallmark of ESCs. These factors trigger stochastic events which lead to the reactivation of 
endogenous pluripotent genes such as Oct4, Nanog, Sox2, from which an auto-regulatory 
network is established and support the pluripotent state independent of transgenes.   
Since the discovery of iPSCs, different strategies are used to induce reprogramming, 
however only a small fraction of donor cells can be successfully induced to iPSCs. Thus the 
reprogramming efficiency seems to be very low. There are several key events which are 
thought to link to reprogramming efficiency such as cell division rate and chromatin structure.  
Inhibition of p53/p21 pathway or overexpression of Lin28 enhance iPSCs generation 
proportionally to the increase in cell division rate (Kawamura et al., 2009; Lapasset et al., 
2011). These observations suggest that accelerated cell division may increase the number of 
donor cells, of which each daughter cell has an independent chance to become iPSC, or DNA 
replication is necessary for epigenetic alteration, such as histone and DNA modifications.  
Another barrier of reprogramming is chromatin structure (Gaspar-Maia et al., 2011). 
The term chromatin was proposed by Walther Flemming in 1882 which means stainable 
material. In 1928, Emil Heitz defined heterochromatin and euchromatin based on differential 
compaction in interphase nuclei. Heterochromatin is more densely stained, compacted, in 
contrast to euchromatin, which are sparsely stained. Compared to somatic cells, ESCs have a 
loosen chromatin structure, euchromatin is more abundant compared to heterochromatin than 
in differentiated cells. In reprogramming assay, the addition of agents which boost chromatin 
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decondensation such as DNMT (DNA methylatransferase) inhibitor 5 aza-cytidine, HDAC 
(Histone deacetylase) inhibitor valproic acid leads to increased reprogramming efficiency 
(Mikkelsen et al., 2008; Huangfu et al., 2008). Overexpression of chromatin remodeling 
complexs such as BAF family components BRG1 and BAF155 (Singhal et al., 2010) also 
promote the reprogramming process. These evidences suggest that re-opening chromatin 
during reprogramming is a key event and promote the opportunity for activating the 
transcriptional network of pluripotency.  
Even though overexpression of four transcription factors OSKM are able to convert 
somatic cells into iPSCs, the overall efficiency is still very slow, which cause a difficulty in 
understanding the molecular mechanism. It has been shown that reprogramming by OSKM is 
a step-by-step process, which involves an early stochastic phase and a deterministic phase. At 
the early stochastic phase, somatic cells have variable latencies, then partially reprogrammed 
cells will go through a hierarchal process to reach pluripotency.  
Since the discovery of OSKM, many groups have tried to substitute these four 
transcription factors by other factors. Among them, c-Myc is the first factor which is 
dispensable and can be replaced by n-Myc, I-Myc or maternal transcription factor Glis-1 
(Wernig et al., 2008; Nakagawa et al., 2008, Maekawa et al., 2011). Nuclear receptor Nr5a2 
and Nr5a1 can replace Oct4 when combined with KSM (Heng et al., 2010). Sox7 and Sox17 
can replaced Sox2 by modified a mutation in the High-Mobility-Group (HMG) DNA-binding 
domain which in turn promotes the binding of Oct4 to canonical Oct-Sox site (Jauch et al., 
2011; Aksoy et al., 2013). Esrrb (Estrogen-related receptor beta) is highly expressed in ES 
cells, can substitute Klf4 (Feng et al., 2009).  
Many chemical approaches also show that small molecule compounds can promote 
reprogramming and replace some or all four factors OSKM. Trichostatin A (TSA), valporic 
acid (VPA), butyrate, and suberoylanilide hydroxamic acid (SAHA) are histone deacetylases 
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inhibitors, which can facilitate the reprogramming process and replace c-Myc (Huangfu et al., 
2008; Mali et al., 2010; Esteban et al., 2010; Blaschke et al., 2013; Stadtfeld et al., 2012). 
Oct4 can be substituted by Forskolin, which is a cAMP agonist. The combination of 
CHIR99021 (a GSK-3 beta inhibitor), 616452 (TGF-beta RI kinase inhibitor II), Forskolin 
and DZNep (S-adenosylhomocysteine hydrolase inhibitor) is able to reprogram mouse 
somatic cells into iPSCs (Hou et al., 2013). Although this cocktail is able to produce iPSCs in 
mice, it fails to induce human cells into iPSCs. These studies indicate that the small 
compound molecules can induce a global open chromatin structure, which assist the 
reprogramming role of OSKM.   
After OSKM are overexpressed, they bind to the genome at many nonfunctional sites, 
due to the high level of overexpressed proteins (Soufi et al., 2012). These nonfunctional sites 
are different from the core OSK targets in vivo, however OSKM also bind near genes which 
facilitate the “on-target” and prevent the “off-target” of the reprogramming process. These 
observations suggest that OSKM not only open up the road to pluripotency but also to other 
cell fates such as cardiogenesis and neurogenesis or apoptosis. This unrestrained binding 
mode of OSKM initially lead to a stochastic phase prior to transitioning to a more 
deterministic phase.  
At first, OSK bind to distal elements of repressed genes due to the inaccessibility to 
promoter regions of these genes. Among four factors OSKM, c-Myc is not a pioneer factor. 
c-Myc binds to OSK and enhance the accessibility of OSK to their targets, which in turn 
amplify the gene expression. Chromatin remodeling complex BAF has been reported to 
enhance the accessibility of Oct4 to promoters and increase the reprogramming efficiency 
without c-Myc (Singhal et al., 2010). In line with the positive effect of chromatin modifier 
BAF, KDM2A and KDM2B are H3K36me2 demethylases; UTX, an H3K27 demethylase; 
WDR5, an “effector” of H3K4 methylation are able to induce open chromatin and increase 
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reprogramming efficiency (Ang et al., 2011; Mansour et al., 2012; Pijnappel et al., 2013). In 
brief, the stochastic events driven by OSKM can be enhanced by inducing global open 
chromatin structure to facilitate the accessibility of OSKM to target genes.  
Follow the initial stochastic phase, a small number of successfully converted cells 
enter a deterministic step. Using the single cell expression profile approach, reactivation of 
endogenous Nanog and Sox2 are predictive of a deterministic pluripotent fate (Buganim et al., 
2012). Moreover, the reactivation of endogenous Gdf3, Dppa2, Dppa3 (Stella) are markers 
for stablization of pluripotency (Golipour et al., 2012).  Interestingly, these stabilization 
marker genes are located in a megabase-scale chromatin domains spanned by H3K9me3, 
which is not accessible in fibroblasts. In conclusion, OSK binding sites are rearranged to 
resemble the in vivo “on-target” sites.   
The chromatin structure of somatic cell is a major target for facilitating 
reprogramming.  Knocking down SUV39H1/H2, H3K9 methyltransferases, significantly 
increase the reprogramming efficiency by removing heterochromatin domain which blocks 
OSKM binding to pluripotent genes (Onder et al., 2012; Sridharan et al., 2013). At the final 
phase of reprogramming, BMP signaling arrests the reprogramming cells in pre-iPSCs by 
inducing high level of H3K9me3. The same study also shows that Vitamin C can reduce 
H3K9me3 level and facilitate the conversion of pre-iPSCs into iPSCs (Chen et al., 2012). 
Depletion of MBD3, a component of NuRD repressor complex, results in a deterministically 
reprogramming process, in which 95% cells are converted to iPSCs (Rais et al., 2013).  At the 
same time, other groups showed that depletion of MBD3 only enhance reprogramming 
moderately (0.15% to 1.5%) (Lou et al., 2013). The high efficiency reported can be due to the 
effect of secondary system reprogramming and medium which contains inhibitors of GSK3-
beta and MEK kinases. At the initial stage, MBD3 seems to be recruited by OSKM at the 
“off-target” sites to form heterochromatin, which blocks the reprogramming process. 
7 
 
Therefore, knocking down of MBD3 may synchronize cells at early stochastic phase (Soufi et 
al., 2014). 
 
1.4 Reprogramming by nuclear transfer 
Reprogramming of somatic cells by nuclear transfer (SCNT) was originally 
demonstrated by injection nuclei of somatic cells into enucleated Xenopus oocytes (Gurdon 
et al., 1958). Since then, reprogramming of mammalian cells by nuclear transfer has been 
successfully done in sheep (Wilmut et al., 1997), mouse (Wakayama et al. 1998) and human 
(Noggleet al., 2011).  
These studies indicate the presence of reprogramming factors in oocyte, which 
influence the epigenome of somatic cell nuclei and reprogram it toward the totipotent state. 
However the molecular events and factors that occur during SCNT are unclear. Recently 
Jullien et al. (2014) shows that mouse somatic nuclei is reprogrammed into an oocyte gene 
expression pattern, rather than that of ESCs or ICM. Moreover reprogramming is independent 
of DNA synthesis and cell cycle replication as previously known.  
In contrast to current protocols for direct reprogramming by Yamanaka four factors, 
reprogramming by SCNT appears to happen in a single event. Moreover, SCNT give rise to 
fully reprogrammed pluripotent cells with no trace of partially reprogrammed cells found in 
iPSC approach (Hasegawa et al., 2010). ESCs derived from SCNT embryo have less 
epigenetic abnormalities compared to iPSCs (Ma et al.,2014).These observation suggests that 
reprogramming by SCNT is a synchronized process in contrast to stochastic processes 
induced by Yamanaka four factors.  
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1.5 Current advances of human iPSCs and implications 
After Yamanaka’s discovery of iPSC generation by overexpressing four transcription 
factors, numerous studies have been done to overcome the limits of low efficiency, safety and 
quality of iPSCs. Firstly, some technical developments have been developed following the 
original viral delivery, which focus on eliminating transgene integration and simplifying the 
methods to achieve high expression of transcription factors. For example: episomal vectors, 
piggyBac transposon, recombinant proteins, minicircle vectors, synthetic mRNA, and so on. 
Depending on the application purpose, the most safety approaches for generating clinical 
grade human iPSCs is recombinant protein. On the other hand, for studying the process and 
mechanism of reprogramming, dox-inducible Piggybac transposon or lentiviral constructs are 
the most robust systems. Second concern about generating human iPSCs is the low efficiency 
of the process. For this area, researches are focused to dissecting the mechanism of 
reprogramming or identify new factors which can augment the process. Recently findings 
indicate that some transcriptions factors, such as Glis-1, L-Myc, and Nr5a2, cell cycle 
regulators, such as p53 and Ink4a locus, and chromatin modifiers, such as VPA and vitamin 
C, or noncoding RNA, such as lincRNA-ROR and mir-302, can enhance the reprogramming 
efficiency in human cells. The third and most important aspect is the quality of iPSCs. In 
testing drugs or regenerative medicine, iPSCs will be induced to differentiate into desired cell 
types before application. Therefore the most important characteristic of iPSCs is the capacity 
to differentiate into any cell types. Some reports have shown that iPSCs have memories and 
easy to be converted into original cell types (Lister et al., 2011; Ohi et al., 2011; Bar-nur et al., 
2011). Bar-nur et al. (2011) evaluated the level of histone H3 acetylation in iPSCs derived 
from beta cells and non-beta cells. They found acetylated H3 at Insulin and Pdx1 genes in 
beta cell-derived iPSCs, even though both genes are not expressed, but not in non-beta cell 
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derived iPSCs or ESCs. The retained memories may cause low differentiation efficiency and 
aberrant phenotypes in differentiated cells derived from iPSCs.  
 
1.6. Spermatogenesis 
The seminiferous tubules contain germ cells and somatic Sertoli cells (Hess et al., 
2008). The Sertoli cells create a microenvironment, which are necessary for maintaining the 
production of spermatozoa. Blood and lymphatic vessels and Leydig cells locate in between 
the seminiferous tubules. These support cells produce growth factors, which are important for 
the development of germ cells. On the other hand, the myoid cells are structural support, 
which have a role in fluid and sperm movement through the lumen of seminiferous tubules. 
The spermatogenesis process can be divided into three phase: mitotic phase, meiotic phase 
and spermiogenesis.  
The spermatogonial stem cells located at the basement of the seminiferous tubules. 
These single spermatogonial cells are called (As) (A single) spermatogonia. As spermatogonia 
have the ability to self-renewal, which can generate spermatogonial stem cells in order to 
preserve the stem cell resource. At the same time, As spermatogonia can divide into 
differentiating spermatogonia, which will go through differentiation process and finally fully 
differentiated germ cells so called sperms.  
One As spermatogonium divides into two differentiating spermatogonia which are 
interconnected via an intercellular bridge. These Apr (A paired) spermatogonia can undergo 
mitotic divisions, which result in a 4, 8, 16, or 32 Aal (A aligned) spermatogonia. Aal 
spermatogonia differentiate without mitotic division into A1 spermatogonia. A1 
spermatogonia undergo mitotic divisions to form series of A2, A3, A4, Intermediate and B 
spermatogonia. B spermatogonia divide mitotically to form primary spermatocytes.  
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Primary spermatocytes start the first meiotic division (M-I), which give rise to 
secondary spermatocytes. Subsequently, the second meiotic division (M-II) occurs and four 
haploid round spermatids are produced from one primary spermatocyte. The spermiogenesis 
can be subdivided into 16 steps based on the morphology. Steps 1-8 contain round spermatids, 
steps 9-16 contain elongating spermatids. Because the spermatogenesis is well-controlled in a 
time regulated manner, the stages of seminiferous tubules can be classified into twelve (I-XII) 
stages based on the developing germ cell types exist.    
Transition protein TNP1 and TNP2 have vital role in nuclear condensation during 
spermiogenesis. They constitute 90% of the chromatin proteins during the histones to 
protamines transition stages. Knock-out of either TNP1 or TNP2 result in a moderate defect 
in spermatogenesis, while double knock-out mice are sterile (Yu et al., 2000; Shirley et al., 
2004). 
 
1.7 Histone replacement during spermiogenesis  
During the elongation phase of spermatogenesis, nuclear chromatin is condensated 
and transcription is suspended. The most important event during this phase is the replacement 
of core histones by transition proteins (TNPs) and finally protamines (PRMs). Recent studies 
indicate that histone modifications such as phosphorylation, ubiquitination or 
hyperacetylation are involved. Monoacetylated and low levels of diacetylated histone H4 are 
enriched in stages which associated with histone deposition or transcriptional active stages. 
Meanwhile, the highly acetylated histones H4 are enriched at the replacement stage 
(Meistrich et al., 1992). Histone ubiquitination has been linked to nucleosome removal during 
the post meiotic phase. Recent work showed that histone ubiquitine by ubiquitin ligase RNF8 
may induce H4K16 acetylation, which facilitate the removal of histone during transition 
11 
 
stages (Lu et al., 2010). SSTK is a small serine/threonine kinase, which phosphorylate 
histones H1, H2A, H2AX, and H3.  SSTK null mice have defect in elongating spermatids, at 
the stage of histones to transition proteins replacement (Spiridonov et al., 2005). These 
observations suggest that TNP1 and TNP2 share overlapping functions. Tnp-null mice also 
show abnormal protamine 2 processing, which result in the abnormal ratio of protamine 1 and 
protamine 2 (Meistrich et al., 2003). Protamines are arginine-rich, DNA-binding proteins in 
the nucleus of vertebrate sperms. These small proteins pack the sperm DNA in a volume less 
than 5% of ordinary somatic cell nucleus. A reduction in the amount of either protamine 1 or 
protamine 2 disrupts the nuclear condensation process (Cho et al., 2001; Jan et al., 2012). 
 
1.8 Histone variants and cellular plasticity  
In eukaryote, DNA is wrapped around core histones to form chromatin, which then 
folded and packed into chromosome. There are 4 core histone proteins: histone H3, histone 
H4, histone H2A and histone H2B, together they form an octamer. Canonical histones are 
synthesized in coordination with DNA replication, while histone variants are non-allelic 
isoforms of canonical histones. Many evidences showed that histone variants are produced in 
order to replace canonical histones during cellular transition.  Histone variants H2A.Z, and 
H3.3 facilitate cellular plasticity in early development. Histone variants H2A.X, H3.3, and 
macroH2A inhibit developmental plasticity following cellular differentiation. Variants H3.3, 
H2A.Z, and H2B.E regulate cellular plasticity in the adult nervous system (Santoro et al., 
2015).   
Prior to the deposition of histones into chromatin, and after removal from chromatin, 
these histones are soluble. Histones are basic proteins, which easily interact with other acidic 
partners, and these interactions may form non-desired aggregations. In order to protect cells 
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from such defects, histones are usually associated with factors known as histone chaperones, 
which can buffer the positive charge. Nucleoplasmin is the first identified histone chaperone 
which involved in the prevention of histone-nucleic acid aggregation.  
Nucleoplasmin was purified from Xenopus lavevis oocytes in 1978. Nucleoplasmin 
functions as a storage pool for histone H2A and H2B dimers. On the other hand, N1 and N2 
proteins are storage pool for histone H3 and H4 dimers. In vertebrates, there are three 
members of nucleoplasmin (NPM1, NPM2, and NPM3). Npm2 forms a homopentamer 
structure which contains five individual 22kDa subunits. Amino acids 16 to 120 form core 
domain for pentamerization and heat stability. NPM2 is phosphorylated in oocyte and heavily 
phosphorylated at meiosis II. This hyperphosphorylation modification is essential for DNA 
decondensation and exchange of protamine of paternal DNA at zygote stage. The 
phosphomimic form of NPM2, in which serine is converted to aspartate showed an enhance 
affinity for histone H2A-H2B dimers (Gurard-Levin et al.). 
Recently we found that mouse TH2A and TH2B (Hist1h2aa and Hist1h2ba) help to 
establish developmental plasticity in the early embryo (Shinagawa et al., 2014). Histone 
variants TH2A and TH2B, which differ from canonical H2A and H2B by 15 and 16 amino 
acids, respectively, were first identified in mammal testis (Trostle-Weige et al., 1982; Shires 
et al., 1976). TH2A and TH2B are highly expressed in oocyte and zygote and gradually 
decreased as differentiation proceeds to blastocyst stage (Figure 1.2) 
Interestingly, TH2A/TH2B double mutant oocytes showed significantly reduced 
ability to develop to blastocyst stage following fertilization compared to wild-type oocytes. 
Moreover the paternal genome activation was shown to be defected in zygotes derived from 
double mutant oocytes. Therefore TH2A and TH2B are maternal effect factors.  
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Indeed overexpressing of TH2A and TH2B with OSKM in mouse embryonic 
fibroblasts carrying Nanog-GFP enhance the generation of GFP positive iPSCs (Figure 1.3). 
Nucleoplasmin (Npm) is a histone chaperone, which is highly expressed in oocytes 
(Laskey et al., 1978; Mills et al., 1980). Npm decamer binds to histone octamer, and 
functions in both storage and deposition of histone octamers onto DNA. After fertilization, 
Npm contributes to the decondensation of sperm chromatin (Philpott et al., 1991). It was 
reported that Npm is heavily phosphorylated during fertilization (Bañuelos et al., 2007). As 
expected, coexpression of phosphorylated form of Npm (P-Npm), TH2A, TH2B and OSKM 
significantly enhanced the OKSM-induced iPSC generation by approximately 18-fold (Figure 
1.3).  
We also found that TH2A, TH2B induce an open chromatin by comparing the 
structural features of nucleosomes containing canonical histones or TH2A/TH2B. The 
number of strong hydrogen bonds in the nucleosomes containing TH2A/TH2B are decreased 
compared with nucleosomes containing canonical histones, which suggests a more open 
chromatin structure exists TH2A/TH2B containing nucleosomes.  
Interestingly, TH2A/TH2B enhance the iPSC generation from Xist mutant MEFs 
compared to wild-type MEFs. A previous study showed that cloning efficiency of Xist mutant 
nuclei by SCNT was much higher than that of wild-type nuclei (Inoue et al., 2010). Thus, the 
addition of TH2A/TH2B to the somatic cell reprogramming process leads to greater 
similarity to oocyte-based reprogramming and SCNT (Figure 1.4).   
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CHAPTER 2. THE ROLE OF MOUSE HISTONE VARIANTS TH2A AND TH2B IN 
CHROMATIN CONFIGURATION 
2. 1 RESEARCH PURPOSE  
Mouse histone variants TH2A, TH2B and P-Npm2 enhance the reprogramming 
process induced by OSKM (Shinagawa et al., 2014). TH2A and TH2B are highly express in 
oocyte and testis, which indicate they may function in oogenesis and spermatogenesis. 
Th2a/Th2b double mutant male mice are sterile (Shinagawa et al., 2015). In this study, the 
role of two histone variants TH2A, TH2B in chromatin configuration is investigated in two 
contexts: 
1.  The role of TH2A and TH2B in reprogramming process through characterization of the 
chromatin features of NIH3T3 cell line overexpressing mouse TH2A, TH2B and P-NPM2.  
2.  The role of TH2A and TH2B in chromatin configuration of spermatids using mutant mice 
lacking both TH2A, TH2B.  
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2.2 MATERIALS AND METHODS 
Animal 
Th2a/Th2b-deficient mice were generated as described (Shinagawa et al.,. 2014). 
Mutant mice were backcrossed with BALB/c mice five times or more before use in the 
experiments.  
 
Immunohistochemical examination of testes 
Testes and caput epididymis were fixed in Bouin's solution overnight, embedded in 
paraffin, and sectioned. Sections were used for hematoxylin and eosin staining, periodic acid 
Schiff (PAS) staining, and immunofluorescence. For immunostaining, sections were 
subjected to antigen retrieval and stained with an anti-TNP2 antibody (Santa Cruz 
Biotechnology) or an anti-γH2AX antibody (Millipore). The secondary antibodies were 
Alexa Fluor 488- or Alexa Fluor 568-conjugated anti-goat or anti-mouse IgGs (Invitrogen).   
 
Preparation of testicular cells 
The testes of two adult mice (8–12 weeks old) were dissected, and the seminiferous 
tubules were released during a 15 min incubation at 37°C in 1 ml of RPMI medium 
containing 1 mg/ml of collagenase (Sigma). The tubules were then allowed to sediment, the 
medium replaced by 1 ml of the RPMI without collagenase, and then washed three times with 
1 ml of RPMI. To make a tubular segment, the resulting sediment was incubated for 15 min 
at 37°C in 1 ml of trypsin solution (50 µl/ml in RPMI; Invitrogen). After adding fetal bovine 
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serum (FBS) to a final concentration of 10%, the germinal and Sertoli cells were released by 
pipetting and filtered through 70 µm pore filters (Becton Dickinson). 
Isolation of round and elongated spermatids 
Velocity sedimentation at unit gravity (STA-PUT gradient) was used to isolate 
spermatocytes, round and elongated spermatids as described (Bryant et al. 2013; Romrell et 
al. 1976). Apparatus was assembled according to the protocol. A linear gradient was 
generated from 275 ml of RPMI medium added with 2% and 4% BSA. Thirty milliliters of 
RPMI medium containing 0.5% BSA were loaded into the loading chamber, followed by ten 
milliliters of testicular cells. After 3 hours of sedimentation, cells were collected in each 
fraction of 14-ml, and numbered as Fraction #1 from the beginning. Fractions were examined 
under microscope. Three first fractions were omitted because of containing heterozygous cell 
population or big cell clumps. Spermatocytes were usually enriched from Fraction # 4-9, 
round spermatids were from 13-18, and elongated spermatids were from 22-27. Fractions 
containing cell of interest were pooled and collected by centrifugation at 500 x g for 10 min. 
 
Separation of chromatin and non-chromatin fraction 
Whole cell extracts, chromatin fraction or non-chromatin fraction from testicular cells 
were used for Western blotting. To separate chromatin and non-chromatin fraction, cells were 
suspended in 5 volume of NETN buffer (50 mM Tris-HCl, pH 8, 100 mM NaCl, 2 mM 
EDTA, 0.5% NP40) for 15 minutes. The pellet and supernatant were separated by 
centrifugation and adjusted to the same volume with sample buffer. After electrophoresis and 
transfer of the proteins to membranes, the membranes were incubated with the indicated 
antibodies and washed in PBS or 0.5% Triton X-100 containing PBS (only for experiments 
using anti-TH2B). The signals were detected using ECL Western Blotting Detection 
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Reagents (GE Healthcare). The following primary antibodies were used: anti-H2A (1:1,500; 
Abcam), anti-H2B (1:2,000, Millipore) anti-TH2A (1:9,000), anti-TH2B (1:5,000), and anti-
H3 (1:10,000; Abcam), anti-H4 (1:1,250; Millipore), anti-protamine 2 (1:300, Santa cruz), 
anti-H3K14ac (1:3,000, Epigentek), anti-actin (1:3,000, Santa cruz).  
 
qRT - PCR 
Total RNA was isolated using Isogen (Nippon Gene).  qRT- PCR  was  performed  
using SuperScript  III  Platinum  SYBR  Green  One-Step  qRT-PCR  kit  (Invitrogen).  
Primer sequences are shown in Table 2.1 
Table 2.1 
 
DNase I Sensitivity 
NIH3T3 cells stably expressing H2A, H2B, and P-Npm, or TH2A, TH2B, and P-Npm, 
were established by retroviral infection. After infection, the cells were selected and 
maintained in medium supplemented with 400 µg/ml G418 (Calbiochem). Nuclei were 
isolated from NIH3T3 cells essentially as described by Rao et al. (1983). Briefly, cells were 
harvested and homogenized in buffer A (10 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 1 mM 
CaCl2, and 40 mM NaHSO3) containing 0.34 M sucrose. After centrifugation, the nuclear 
pellet was obtained, washed in buffer A containing 0.34 M sucrose, and suspended in 3 ml of 
the same buffer. The sample was overlaid on 2 ml of buffer A containing 1.8 M sucrose and 
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centrifuged at 13,500 rpm for 19 min at 4 °C in a Beckman SW55Ti rotor. The nuclear pellet 
was washed sequentially once each with 1 M and 0.34 M sucrose in buffer A. The washed 
nuclear pellet was suspended in suspension buffer (50 mM Tris-HCI, pH 7.4, 25 mM KCl, 5 
mM MgCl2, 0.1 mM PMSF, and 0.1% Triton X-100) and centrifuged. The resulting pellet 
was washed once with digestion buffer (10 mM Tris-HCI, pH 7.4, 10 mM NaCl, 5 mM 
MgCl2, 0.1 mM PMSF, and protease inhibitor cocktail) and stored at 4°C until use. Digestion 
was carried out in the same buffer at a nuclear concentration of 1.6 A260 units/ml (measured 
in 2 M NaCl and 5 M urea) with 0.0563 U/µl of DNase I (Promega) at 37 °C, as described by 
Miesky (1971). Digestion kinetics were followed by measuring at 260 nm the amount of 
DNA that was soluble in 0.166 M perchloric acid and 0.166 M NaCl. The experiment was 
repeated three times using three independent samples. The data were analyzed in accordance 
with their normal distribution by an independent t-test. 
 
Micrococcal Nuclease Sensitivity 
MNase sensitivity was examined essentially as described by Chandrasekharan et al. 
(2009). NIH3T3 cells grown to near confluence were harvested and suspended in ice-cold 
RSB (10 mM HEPES-NaOH, pH 7.4, 15 mM NaCl, and 1.5 mM MgCl2) containing 1% 
Triton X-100 and protease inhibitor cocktail. The cells were disrupted using a Dounce 
homogenizer. Nuclei were collected by centrifugation and washed twice with buffer B (15 
mM HEPES-NaOH, pH 7.4, 15 mM NaCl, 60 mM KCl, 0.34 M sucrose, 0.5 mM spermine, 1 
mM dithiothreitol (DTT), and protease inhibitor cocktail). The nuclear pellet was 
resuspended in 10 volumes of storage buffer (20 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 10% 
glycerol, 100 mM KCl, 1 mM DTT, protease inhibitor cocktail, and 5 mM N-
ethylmaleimide) and stored until use. The number of nuclei was determined by measuring the 
optical density at 260 nm using an aliquot resuspended in 1 N NaOH. In MNase digestion 
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buffer (10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 5 mM KCl, and 0.2 mM EDTA) containing 2 
mM CaCl2, nuclei were digested by MNase (Takara) at a concentration of 10, 30, 60, and 90 
U/ml for 10 min at 37 °C. The digestion was terminated by adding stop buffer (50 mM Tris-
HCl (pH 8.8), 20 mM EDTA, and 0.5% SDS) and treated with 2 mg/ml proteinase K (Roche) 
for 1 h at 42 °C. The DNA was purified by phenol-chloroform extraction and digestion with 5 
µg/ml RNase (30 min at 37°C, Nakalai Tesque), followed by a second phenol-chloroform 
extraction. Equal amounts of DNA (300 ng/lane) were analyzed by 2.0% agarose gel 
electrophoresis and stained with ethidium bromide for visualization. 
 
Measurement of the Levels of Histone H3K9me3 
The levels of histone H3K9me3 were measured using the EpiQuick global H3K9me3 
quantification kit following the manufacturer’s protocol (Epigentek). Briefly, after the 
isolation of nuclei from NIH3T3 cells, histones were prepared by acid extraction. The histone 
fractions were then spotted on wells coated with anti-H3K9me3 antibodies by incubation at 
RT for 60 min. The amount of H3K9me3 was quantified using the microplate reader via a 
colorimetric reaction at a wavelength of 450 nm. The experiment was repeated three times, 
and the mean value was acquired. The data were analyzed by an independent t-test. For the 
control, active and inactive chromatin fractions were prepared essentially as described by 
Fierz et al. (2011) and Tachiwana et al. (2010). Nuclei were isolated from NIH3T3 cells as 
described previously for the MNase sensitivity experiments. In the presence of 1 mM CaCl2, 
nuclei were digested in MNase digestion buffer with 12 x 10–2 U/µl MNase for 12 min at 
37 °C. The digestion was stopped by the addition of 10 mM EDTA, and the sample was 
centrifuged at 10,000 g for 10 min at 4 °C. The supernatant (S1) was collected, and the pellet 
was suspended in 10 mM EDTA, pH 8.0/150 mM NaCl solution. The sample was again 
centrifuged at 20,000 g for 10 min, and the supernatant (S2) was collected. The combined 
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fractions of S1 and S2 were used as an active chromatin fraction. The pellet was extracted 
with 0.4 N H2SO4, followed by TCA precipitation, and was used as an inactive chromatin 
fraction. 
 
H3K9me3 Immunostaining of NIH3T3 Cells 
NIH3T3 cells were washed once with TBS (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 
2 mM KCl) for 10 min, and fixed with 80% ethanol for 15 min at RT. Cells were 
permeabilized with TBS containing 1% Triton X-100 for 10 min and blocked with 3% BSA 
in PBS for 10 min, followed by an incubation overnight at 4 °C with the primary antibodies 
rabbit anti-TH2B (1:200) and mouse anti-H3K9me3 (1:200). Cells were then incubated with 
the secondary antibodies Alexa Fluor 488 goat anti-rabbit IgG (1:300) and Alexa Fluor 546 
goat anti-mouse IgG (1:300; Invitrogen). After washing, cells were incubated with TO-PRO-
3 (1:1,000; Invitrogen) for 10 min at RT, washed with H2O, and mounted in ProLong Gold 
(Invitrogen). Samples were analyzed using a ZEISS LSM 510 confocal microscope. 
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2.3 RESULTS 
2.3.1 Overexpressed TH2A/TH2B induce an open chromatin structure in NIH3T3 cells 
To understand the mechanism by which TH2A and TH2B regulate chromatin 
structure, the DNase I sensitivity of nucleosomes containing TH2A/TH2B was compared to  
those containing canonical histones. NIH3T3 cell pool expressing TH2A/TH2B or H2A/H2B 
at a relatively high level were generated by the selection of neor cells after infection with a 
retrovirus expressing both TH2A/TH2B or H2A/H2B and the neor gene. In these NIH3T3 
cells, the expression levels of TH2A and TH2B relative to endogenous H2A and H2B were 
32% and 33%, respectively, and most of the TH2A/TH2B was deposited into chromatin (Fig. 
2.1). The nuclei from NIH3T3 cells expressing TH2A, TH2B, and P-Npm exhibited higher 
DNase I sensitivity than those from cells overexpressing canonical histones (Fig. 2.2).  
There was no difference in the micrococcal nuclease (MNase) sensitivity of the nuclei 
from those two cell pools overexpressing TH2A/TH2B or H2A/H2B (Fig. 2.3). TH2A/TH2B 
also did not affect the level of histone H3K9me3 (Fig. 2.4 and 2.5).  Overall these results 
suggest that the presence of TH2A/TH2B induces a more open chromatin structure.  
 
2.3.2 Defects in the deposition of TNP2 on chromatin in Th2a-/-Th2b-/- spermatids  
  During spermiogenesis, histones are replaced by transition nuclear proteins (TNP1 
and TNP2), which are then replaced by protamines (Gaucher et al., 2010). The TNP2 
immunostaining signal in mutant spermatids lacking TH2A/TH2B decreased substantially 
compared with that of the wild-type control (Fig. 2.6A). An abnormal nuclear morphology 
was evident in the mutant spermatids (Fig. 2.6B), although the level of Tnp2 mRNA in 
mutant and wild-type testes was similar (Fig. 2.7).   
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The levels of TNP2 and protamine 2 in mutant spermatid extracts were lower than 
those in the controls (Fig. 2.6C). When spermatid whole extracts were separated into 
chromatin and non-chromatin fractions, TNP2 and protamine 2 were predominantly 
recovered in the chromatin fraction and their levels in the mutant chromatin fraction were 
lower than those in the wild-type chromatin fraction, suggesting a defect in the chromatin 
incorporation of TNP2. Because there were no differences in the mRNA levels of several 
genes (Prm1, FoxJ1, Ube2a, Rnf12, and Tpap) between wild-type and mutant spermatids 
with haploid genomes (Fig. 2.7), the defect in histone replacement may have been due to an 
abnormality in chromatin structure rather than a decrease in haploid genome expression. In 
addition, there was moderate differential expression in a few dozen genes in spermatocytes of 
mutant and wild-type testes (data not shown), suggesting that it was unlikely that the loss of 
Th2a and Th2b genes in spermatogonial stem cells caused these defects in spermatogenesis. 
The results of western blot analysis of round and elongating spermatid extracts indicated that 
the H2A level was similar between the spermatids of wild-type and mutant mice, while the 
H2B level was higher in mutant spermatids than in the control spermatids (Fig. 2.8), 
suggesting the presence of a feedback mechanism.  
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2.4 DISCUSSION 
 Open chromatin is a hallmark of ESCs and iPSCs, in which the overall genome is 
hyperactive and the levels of heterochromatin are reduced compared with differentiated cells 
(Efroni et al., 2008). The open chromatin state in ESCs is maintained by multiple chromatin 
remodeling factors, including Chd1 and the TIP60-p400 complex (Gaspar-Maia et al., 2009; 
Fazzio et al., 2008). Reduction of the Chd1 level in ESCs increased the amount of 
heterochromatin, whereas expression of TH2A/TH2B did not affect the level of H3K9me3, a 
typical marker of heterochromatin. These results suggest that TH2A/TH2B contribute to the 
reprogramming of somatic cells by inducing transcriptionally active open chromatin, whereas 
Chd1 contributes to the maintenance of an established open chromatin state in ESCs by 
suppressing heterochromatin formation.   
In spermatogenesis, it is reported that TH2B levels in spermatocytes and spermatids 
are approximately two-fold higher than the H2B level (Lu et al., 2009). However, the H2A 
levels were not significantly different in the mutant cells. We speculate that the loss of 
TH2A/TH2B blocks the replacement of histones during spermiogenesis Recently, Montellier 
et al. (2013) reported that mutant mice lacking TH2B expression exhibit no defect during 
spermiogenesis, indicating that a loss of TH2B alone is not sufficient to disturb histone 
replacement. Thus, loss of both TH2A and TH2B may be necessary to impair histone 
replacement and the normal release of cohesion at interkinesis. However, the possibility that 
such defects are due to a decrease in the total histone level cannot be excluded. In the mutant 
testis, the lack of TH2B was compensated by over-expression of H2B, whereas 
overexpression of H2A was not observed. Thus, the total amount of histones in the mutant 
cells was lower than that in the wild-type cells. Multiple mechanisms may act in combination 
to destabilize the nucleosome and replace the histones. Hyperacetylation of canonical 
histones during spermatogenesis, especially H4, and multiple histone variants are thought to 
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weaken DNA–histone octamers and nucleosome–nucleosome interactions (Govin et al., 
2007; Gaucher et al., 2010). Nucleosomes containing hyperacetylated histones are thought to 
be more prone to displacement by protamines (Oliva et al., 1987). These previous reports are 
consistent with the observations that TH2A/TH2B, which induce an open chromatin structure, 
are required for the replacement of histones by TNPs .  
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CHAPTER 3. THE ROLE OF HUMAN HISTONE VARIANTS TH2A AND TH2B IN 
REPROGRAMMING  
3.1 RESEARCH PURPOSE 
Human TH2A and TH2B have high homology with mouse TH2AandTH2B 
respectively. Human TH2A and TH2B shared the same promoter as mouse TH2A and TH2B. 
Compared to canonical histone H2A and H2B, TH2A and TH2B differ at C-terminal and N-
terminal respectively (Figure 4.1). TH2B is highly expressed during human spermatogenesis 
(Zalensky et al. 2002) and forms unstable octamer, as demonstrated in mouse (Li et al., 2005; 
Shinagawa et al., 2014). Histone chaperone NPM2 is also highly enriched in oocyte (Yan et 
al., 2013) and humanNPM2 has 66% identity with mouse NPM2. In the case of mice, co-
expression of phosphorylation-mimic form of Npm2 enhanced the reprogramming efficiency 
in combination with TH2A, TH2B, and OSKM (Shinagawa et al., 2014).Therefore human 
TH2A, TH2B, and phosphorylation-mimic form of NPM2 (P-NPM2)may also have positive 
effects on reprogramming of human cells.  
My purpose is testing whether induction of human TH2A, TH2B, and P-NPM2 can 
enhance reprogramming in two different primary cell types (human umbilical endothelial 
vein cells and adult human dermal fibroblasts). Another aspect is characterization of iPSCs 
generated by OSKM and TH2A, TH2B, P-NPM2 by genome wide expression profile and 
teratoma formation capacity compared to iPSCs generated by OSKM.   
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3.2 MATERIALS AND METHODS 
Plasmid Construction  
TH2A (HIST1H2AA, NM_170745.3) and TH2B (HIST1H2BA, NM_170610.2) were 
amplified from genomic DNA by PCR and inserted into pLenti6.3 vector. Primer sequences 
for generating plasmid were listed in Table 3.1 
Expressions of TH2A and TH2B in adult human dermal fibroblasts (HDFs) infected 
with those expression vectors were confirmed by Western blot with anti-TH2A and anti-
TH2B antibodies (Shinagawa et al., 2014). Prediction of phosphorylation sites of NPM2 was 
carried out by using KinasePhos (Huang et al., 2005). Phosphorylation-mimic nucleoplasmin 
P-NPM was custom synthesized from Operon Biotechnologies Inc. (Tokyo, Japan), in which 
10 putative phosphorylated amino acid residues (4, 5, 7, 8, 9, 86, 99, 191, 196, and 204) were 
substituted to Asp.  
 
Generation and Maintenance of Human iPSCs 
Adult human dermal fibroblasts (HDFs) and human umbilical vein endothelial cells 
(HUVECs) were purchased from LifeTechnologies (Waltham, MA). HDFs and HUVECs 
were passaged once and stored at -80°C before use. HDFs were maintained in fibroblast 
medium (Medium M106with LSGS supplement, Life Technologies). HUVECs were 
maintained in EGM-2 BulletKit (LifeTechnologies). Human neonatal dermal fibroblasts (CC-
2509) we obtained from Lonza-Life Technologies, and maintained in FGM-2 BulletKit 
fibroblast medium(Life Technologies). 
Lentivirus system was used to generate induced pluripotent stem cells. Plasmids 
pSIN4-EF2-O2S and pSIN4-CMV-K2M (Yu et al., 2009) were obtained from Addgene 
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(Cambridge, MA) (#21162 and #21164). Four millions of 293T cells were plated in 10 cm 
dish 1 day before transfection. Lentiviral vectors were packaged with a pLP1, pLP2, and 
pLP/VSVG (Life Technologies) or psPAX2, pMD2.G (Addgene) for pLenti 6.3 and pSIN4 
respectively. Virus containing supernatant was concentrated by LentiX concentrator 
(Clontech,Mountain View, CA), finally suspended in 1/10 volume of medium. Fifty thousand 
HDFs and HUVECs were infected with a mixture of each 50 µl lentiviral vector solution for 
24 hours 3 hours, respectively. Empty vector viral solution was used to adjust the volume. 
Virus containing medium was change to fibroblast medium or EGM medium and cells were 
cultured for 48 hours. Infected cells were passage 1/4into 6-well plate containing mitomycin 
C treated MEFs as feeders. Cells were maintained in human ES medium (20% Knockout 
serum replacement [Life Technologies], 10 ng/ml bFGF, 1 mM glutamine, 100 µM non-
essential amino acid, 100 µM 2-mercaptoethanol, 50 unit/ml streptomycin/penicillin in 
Knockout DMEM). 
Individual colonies were picked up and expanded. Cells were passaged every 3 days 
by CTK solution (containing 0.1 mg/ml collagenase type IV (Sigma) and 0.025% trypsin 
(Life Technologies), 1 µM CaCl2 and 20% Knockout serum replacement in water).  
In some case, adult HDFs were infected with virus to express BAN or empty vector 
for 24 hours. Infected cells were then cultured in fibroblast medium and passaged once. After 
5 days infection, cells were infected with virus to express OSKM as described. 
 
Cell proliferation assay 
At day 0, adult human fibroblasts were seeded at indicated number. Same amount of 
virus-containing medium as mentioned above were used to infect cells for 24 hours. Infected 
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cells were counted at day 5 and day 8 post infection by Countess II Automated Cell Counter 
(Life Technologies). 
 
Immunofluorescence Staining 
Live cell staining was performed with anti-SSEA4 (BD Biosciences) and anti-TRA-1-
60 antibodies (BD Biosciences). First antibody was diluted 1/300, second antibody was 
diluted 1/500 in cell culture medium, mixed and stood for 2 minutes. Cells were incubated 
with diluted antibody for 45 minutes at 37°C. Antibodies were removed and washed twice 
with human ES medium. Images were taken immediately after staining.  
For staining ofOCT4 and NANOG, cells were fixed by 2% paraformaldehyde in PBS, 
permeabilized with 1% Triton-X100 in PBS, then incubated with anti-OCT4 (Santa Cruz) 
and anti-NANOG (Abcam) antibodies diluted in 1% BSA in PBS for 2 hours at room 
temperature. Secondary antibodies (Life Technologies) were diluted 1/1000 in 1% BSA in 
PBS for 2 hours at room temperature. Nuclei were stained by Hoechst 33342. Slides were 
mounted in Prolong Gold (Invitrogen). Images were taken by ZEISS LSM 510 confocal 
microscope. 
For immunohistochemistry, tissues were fixed in 4% PFA in PBS at 4°C for 3 hours, 
embedded in paraffin, and sectioned into 5 µm thickness. Following antibodies were used: 
anti-SMA, anti-TUJ1, anti-AFP (Invitrogen). 
 
Alkaline Phosphatase Staining  
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Alkaline phosphatase staining was performed according to the instruction of 
Leukocyte Alkaline Phosphatase Kit (Sigma-Aldrich, St. Louis, MO). Cells were fixed with 
2% paraformaldehyde in PBS for 1-2 minutes. Fixed cells were incubated in alkaline staining 
solution for 15 minutes at room temperature in dark.  
 
In vitro differentiation 
iPSCs were dissociated with CTK solution as described above. Confluent iPSCs in 
one well of 12-well-plate were collected and suspended in 1 ml of human ES medium 
without bFGF. Cells were transferred into 12-well non-adherent plate and culture for 3 days 
to form embryoid bodies. Embryoid bodies were transferred into adherent plate for 
spontaneous differentiation. Six days after transfer, differentiated cells were fixed and stained 
with antibodies against SMA, TUJ1, and AFP (Invitrogen).  
 
Teratoma Formation 
Teratoma formation was performed as described by Gropp et al. (2012). iPSCs were 
dissociated into single cells by accutase and pass through a 70 µm cell strainer. 5x105 iPSCs 
were mixed with 5x105 mitomycinC treated MEFs and suspended in 50 µl of PBS. For 
negative control, 1x106 mitomycinC treated MEFs were used. Cells were combined with 50 
µl Matrigel (BDBiosciences, San Jose, CA) immediately before transplantation and injected 
subcutaneously into the dorsal flanks of NOD/ShiJic-scidJcl (NOD/SCID) mice (Clea Japan, 
Tokyo, Japan).  
Teratomas were dissected 6-9 weeks after injection.  
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To analyze the area occupied by epithelial-like structures, images of nonconsecutive 
sections (n = 10-12) of each teratoma were acquired and processed by Zeiss Axio Vision 
4.8.2. For each teratoma, the areas of 100 to 120 epithelial-like structures were randomly 
selected and their sizes were measured. 
 
Hematoxylin and eosin staining 
Tissues were fixed in 4% PFA at 4°C for 3 hours. After fixation, tissues were 
dehydrated by ethanol and butanol, finally were embedded in paraffin. Fixed tissues were 
sectioned into 5 µm thickness. Sections were rehydrated and stained with Mayer’s 
hematoxylin (Wako, Tokyo, Japan) for 10 minutes, then rinsed with tap water for 15 minutes, 
finally stained with 1% eosin for 15 minutes. Stained sections were dehydrated and mounted 
in Entellanneu (Merck).  
 
Quantitative RT-PCR (qRT-PCR) 
RNAs were extracted by Qiagen Rneasy Minikit (Qiagen). Total RNA (100 ng) was 
used for qRT-PCR reaction by RNA direct SYBR Green realtime PCR master mix (Toyobo, 
Osaka, Japan). Sequence specific primers were listed in Table 3.2.  
 
Microarray analysis 
Total RNAs were extracted by ISOGEN (Nippongene) from 3 independent OSKM 
iPSC clones and 3 independent OSKMBAN iPSC clones. Total RNAs were amplified by 
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Ambion WT Expression Kit (Life Technologies) and hybridized to Human Gene 1.0 ST 
Array (Affymetrix).  
 
Data processing  
Microarray data was processed with R package Oligo (http://www.r-project.org). 
RMA algorithm was used to normalize all the expression data at the same time. GEO dataset 
for human fibroblasts and human embryonic stem cells were retrieved from GSE23034 (Ohi 
et al., 2011). GSEA (Gene Set Enrichment Analysis) (Subramanian et al., 2005) was 
performed by default setting, except that the minimum size and maximum of gene set were 
set to 30 and 400 respectively. For GSEA of naïve stem cells, four fold up- or down-regulated 
transcripts by naïve stem cells compared to primed stem cells (Theunissen et al., 2014) were 
used for up- or down-regulated naïve stem cells transcripts gene sets. GSEA analysis were 
performed by default setting.  
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Table 3.1 Specific primers for qRT-PCR 
 Forward (5'-3') Reverse (5'-3') 
GAPDH CCCCAGCAAGAGCACAAGAG AGGGGAGATTCAGTGTGGTG 
Exogenous 
SOX2 
GGCCATTAACGGCACACTG TGCTTCTAGCCAGGCACAAT 
Exogenous 
c-MYC 
GGGGACGTGGTTTTCCTTTG 
 
TTCTCCTCCTCGTCGCAGTA 
NANOG CAATGGTGTGACGCAGAAGG GAAGGTTCCCAGTCGGGTTC 
Endogenous 
OCT4 
TTGGGAACACAAAGGGTGGG ACTGTGTCCCAGGCTTCTTTA 
GDF3  ATCCCTGTCCCCAAGCTTTC AACCCAGGTCCCGGAAGTTA 
 
Table 3.2. Primers for plasmid construction  
Name Sequence 
SpeI-NPM-F ATCGACTAGTCCACCATGAATCTCGATG ACGCCG 
XhoI-NPM-rev AATGCTCGAG TCATTTCTTGAATCCTGGCTTC 
H2AA-SpeI-F AGTAACTAGTCCACCATGTCTGGACGAGGGAAG 
H2AA-XhoI-R 
 
AGTACTCGAGTTACTTGCTTTGGGCTTT 
H2BA-SpeI-F AGTAACTAGTCACCATGCCGGAGGT 
H2BA-XhoI-R AGCTCTCGAGTTACTTGGAGCTGGTGTACT 
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3.3 RESULTS 
3.3.1 Human TH2A, TH2B, and NPM2 enhance the reprogramming 
To determine whether human TH2A, TH2B and NPM2 (BAN) have a role in 
reprogramming, I coexpress OCT4, SOX2, KLF4, and c-MYC with BAN in human primary 
cells.  
Human umbilical vein endothelial cells (HUVECs) are reported as easily 
reprogrammed cells and its source is abundant and noninvasive. Thus I first examined 
whether efficiency of OSKM-induced iPSC generation is affected by overexpression ofTH2B, 
TH2A, and phosphorylation-mimic form of NPM2 in HUVECs. To detect reprogrammed 
cells, live cells were stained with anti-TRA-1-60 antibody (Chan et al., 2009). After 11 days 
post infection, BAN enhanced the generation of OSKM-induced TRA-1-60 positive colonies 
7.6-fold (Fig. 3.2A). At day 16, higher number of alkaline phosphatase positive colonies were 
observed in cells induced BAN and OSKM compared to OSKM alone (Fig. 3.2B). To further 
confirm the data, I perform staining of SSEA4, another marker for reprogrammed cells (Chan 
et al., 2009). SSEA4 positive colony number was also increased by the addition of BAN (Fig. 
3.2C). As for application in regenerative medicine, human adult dermal fibroblasts (HDFs) 
are better sources, which can be collected from people with an acceptable damage. BAN also 
enhance the reprogramming of HDFs by2.2 fold (Fig. 3.3A). When neonatal human dermal 
fibroblasts (neonatal HDFs) were used, BAN also enhanced the reprogramming by 2.2-fold 
(Fig. 3.3B). I also tested whether prolonged BAN expression modulates reprogramming 
efficiency of adult HDFs, because adult HDFs are better cell source compared to neonatal 
HDFs for application purpose. Cells were infected with virus to express BAN or empty 
vector for 24 hours. Infected cells were cultured in fibroblast medium and passaged once. 
After 5 days infection, cells were infected with virus to express OSKM. At day 16 after 
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OSKM infection, the number of SSEA4-positive colony was enhanced 10.7-fold by 
prolonged BAN expression (Figure 3.4). This observation suggests that much amount of 
histone variant TH2A/TH2B need time to be incooporated into chromatin prior to OSKM 
expression 
Colonies generated by OSKMBAN from HDFs expressed NANOG and OCT4 with 
the typical homogenous nuclear staining pattern and showed flat morphology similar to 
human ESCs or iPSCs (Fig. 3.5).  Of note, overexpression of BAN did not affect the 
proliferation rate of human adult dermal fibroblasts (Figure 3.6).   
Taken together, BAN can enhance the reprogramming process in human cells. 
 
3.3.2 Differentiation capacity of OSKMBAN iPSCs 
To investigate the pluripotency of human iPSCs generated by OSKMBAN, I 
performed the in vitro and in vivo differentiation assay. After 9 days of culture in 
differentiation medium, clones of OSKMBAN iPSCs expressed the markers for three germ 
layers: beta-III tubulin (TUJ1) for ectoderm, smooth muscle actin (SMA) for mesoderm, and 
alpha-fetoprotein (AFP) for endoderm (Fig. 3.7). Subcutaneous injection of iPSC clones into 
SCID/NOD mice generate teratomas5-9 weeks later (Fig. 3.8). Hematoxylin and eosin 
staining of teratomas showed morphology of chondrocytes (mesoderm), neural rosette 
(ectoderm), and epithelial-like structure (endoderm) (Fig. 3.9A), and they were further 
confirmed by immunostaining of the three germ layer markers (Fig. 3.9B). Teratomas derived 
from OSKMBAN iPSCs contain more diverse structure and high density of epithelium-like 
area than that from OSKM iPSCs (Fig. 3.10).These results suggest that OSKMBAN iPSCs 
have a better differentiation capacity than OSKM iPSCs in vivo.  
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3.4.3 Gene expression profiles of OSKMBAN iPSCs 
To understand how TH2A, TH2B and NPM2 affect the characteristic of OSKMBAN 
iPSCs at molecular level, whole transcript expression analysis was performed. Three 
individual clones of OSKMBAN iPSCs and three individual clones of OSKM iPSCs as 
control were used for study of whole genome expression by Human Gene 1.0 ST array. 
Human ESCs and fibroblasts data of the same platform (Ohi et al., 2011) were used for 
comparison. OSKMBAN iPSC clones are clustered with OSKM iPSC clones in the same 
group with human embryonic stem cells, indicating that OSKMBAN iPSCs possess similar 
properties with human ESCs at gene expression level (Fig. 3.11). The pluripotent group 
containing human ESCs, OSKM iPSCs and OSKMBAN iPSCs is distant from human 
fibroblasts group. The scatter plot of average gene expression levels of three OSKMBAN 
iPSC clones and fibroblasts indicates that OSKMBAN iPSCs are distinct from fibroblasts 
(Fig. 3.12). The pluripotent markers (OCT4, SOX2, NANOG, ZFP42 and GDF3) shown in 
red dots are highly expressed in OSKMBAN iPSCs than fibroblasts. Expression patterns of 
OSKMBAN iPSCs show a higher similarity to OSKM-induced iPSCs (r2=0.99) than that of 
human ESCs (r2=0.96). To confirm the data, expression levels of endogenous OCT4, 
NANOG, and GDF3 were measured by qRT-PCR (Fig. 3.13). These pluripotent genes 
showed high expression in OSKMBAN iPSCs and OSKM iPSCs compared to human 
fibroblasts.   
One of the characteristics of pluripotent stem cells is the suppression of retroviral and 
lentiviral transgenes. Expression levels of c-MYC and SOX2 from lentiviral vector in iPSC 
clones were compared (Fig. 3.14).Exogenous c-MYC expression driven by CMV promoter 
was significantly downregulated in all iPSC clones. On the other hand, SOX2 was 
persistently expressed under the control ofEF1 promoter, suggesting that EF1 promoter is 
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relatively resistant to suppression in pluripotent cells in agreement with previous study (Xia 
et al., 2007).   
 
To evaluate the differences of expression profile between OSKMBAN and OSKM 
iPSCs, I performed the gene set enrichment analysis (GSEA) (Subramanian et al., 2005). 
Upregulated genes in OSKMBAN iPSCs were involved in pathways including glycolysis and 
JAK-STAT pathway (Fig. 3.15). Recently human ESCs andiPSCs which appear to be similar 
to naïve mouse ESCs have been reported (Gafni et al., 2013; Takashima et al., 2014; Ware et 
al., 2014; Theunissen et al., 2014). These naïve pluripotent stem cells develop high grade 
teratoma and the same property was observed in OSKMBAN iPSCs. Thus I perform the 
GSEA comparing up or down regulated genes in OSKMBAN iPSCs to OSKM iPSCs and up- 
or down-regulated genes in human naïve ESCs to primed ESCs (Theunissen et al., 2014). 
Transcripts which show more than4 fold up- or down-regulation were used for analysis. 
GSEA analysis revealed that upregulated genes in OSKMBAN iPSCs are significantly 
enriched in the upregulated gene set of naïve ESCs. On the other hand, genes up-regulated in 
OSKM iPSCs are significantly enriched in the gene set down-regulated in naïve stem 
cells(Fig. 3.16). These data suggest that TH2A, TH2B, and NPM2 may regulate genes which 
involve in naïve state of pluripotency.  
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3.4 DISCUSSION 
In this study, human TH2A, TH2B and P-NPM2 are shown to enhance 
reprogramming by Yamanaka 4 factors and resulting iPSCs exhibit high differentiation 
capacity in vitro and in vivo. Hematoxylin and eosin staining analysis confirmed that after 
transplantation into NOD/SCID mice, human OSKMBAN iPSCs formed well-differentiated 
teratomas, which consisted of all three germ layers, including chondrocytes (mesoderm), 
neural rosette (ectoderm), and epithelial-like structure (endoderm). These data suggests that 
OSKMBAN iPSCs can readily differentiate into other cell phenotypes. It has been reported 
that cell origin of iPSCs can affect the range of differentiation due to aberrant DNA 
methylation on genome (Lister et al., 2011; Ohi et al., 2011; Bar-nur et al., 2011). TH2A, 
TH2B, and P-NPM2 may have an influence on DNA demethylation process by forming open 
chromatin structure (Shinagawa et al., 2014). 
Compared to canonical histones, histone variants are only different in several amino 
acids which resulting in different functions. One of the most well studied histone variants is 
histone H3.3, which is highly conserved in metazoan.  Histone H3.3 differs from canonical 
histone H3.1/H3.2 by only four to five amino acids. H3.3 is associated with active transcribed 
genes by recruiting  histone modifications associated with gene activation such as K4, K36 
and K79 methylation and K9 and K14 acetylation, which are hallmarks of open chromatin 
structure. Moreover histone H3.3 form unstable nucleosomes and promote gene activation 
among with histone H2A.Z (Jang et al., 2015). Since TH2A and TH2B are also differ by 
several amino acids compared to canonical histone H2A and H2B, TH2A and TH2B have a 
positive role in reprogramming. There observations suggest that each amino acid in the 
histone structure is important and specify the role of histone.   
The tails of histones are key players for modulating chromatin activity. Compared to 
H2A and H2B, TH2A and TH2B are differ by the C-terminal and N-terminal respectively. 
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Histone H2A C-terminal tail regulates chromatin structure and dynamics (Vogler et al., 2010). 
H2A C-terminal tail stabilizes the nucleosome core particle, as well as mediates protein-
protein interaction with chromatin remodelers and linker histone H1. Histone H2B N-
terminal tail has been reported to linked to nucleosome stability (Iwasaki et al., 2013). 
Moreover, most of histone posttranslational modifications exist in the N-terminal tail (Parra 
et al., 2006). Multiple lysine acetylation residues have been reported in the N-terminal tail of 
H2B (K6, K11, K16, K17, K21 and K22). The acetylation in this domain is required for 
transcriptional activation in gene-specific context.  Taken together, the difference in C-
terminal and N-terminal of TH2A and TH2B compared to H2A and H2B may result in a 
more striking distinct function. TH2A and TH2B tails may recruit specific chromatin 
remodeling proteins, which can act to recruit other histone H3/H4 modifications. 
Coimmunoprecipitation experiments to identify proteins which interact with TH2A/TH2B 
tails may shed light into the function of these histone variants.   
Since histone modifications play a vital role in the function of histones, TH2A and 
TH2B posttranslational modifications may also have critical role. In the reprogramming 
process triggered by Yamanaka four factors, starting materials are somatic cells. On the other 
hand, TH2A and TH2B are specifically expressed in later stages of spermatogenesis and 
mature oocyte. Some factors which are responsible for TH2A and TH2B posttranslational 
modifications may not exist in somatic cells, therefore in the somatic cell context, TH2A and 
TH2B may not get sufficient modifications. To explore these possibilities, TH2A and TH2B 
posttranslational modifications should be identified by mass spectrometry in spermatogenesis 
or ideally in mature oocytes.  
During the developmental process, the zygote, which is totipotent, gradually lose its 
developmental capacity and commits to cell fate decisions. This process is driven by cross-
antagonistic transcription factors. The simplest model is that a transcription factor promote a 
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specific cell fate by repress an alternative different pattern. Although cell identity is stable, it 
can be altered by ectopic expression of four transcription factors OSKM.  The expression of 
these four factors destabilize the somatic gene network and establish the ES-like phenotype. 
In addition to modifying the transcriptional network, overexpression of four factors OSKM 
during reprogramming induce large scale chromatin remodeling, which finally lead to an 
open chromatin structure similar to ESCs. Upon binding to their target sites, OSK enable the 
binding of other transcription factors and/or recruit histone modifiers. In addition, the binding 
of these OSK can induce locus-specific DNA demethylation.  Therefore in this model, the 
chromatin change is not involved in the reprogramming process, but rather reflects the 
successful establishment of pluripotent state.  
In contrast to this viewpoint, recent studies suggest a more important role of 
chromatin in early stage of reprogramming. Soufi et al. (2012) showed that repressive histone 
modifications and heterochromatin block the initial binding of OSK in early reprogramming 
stage. Moreover, in trans-differentiation process, repressive chromatin is also responsible for 
the failure of gene network reactivation (Cahan et al., 2014; Morris et al., 2014). Especially in 
reprogramming, H3K9me2/me3 histone modifications, which are repressive markers, and 
DNA 5mC modification are reported to be a barrier (Mikkelsen et al., 2008; Lister et al., 
2011; Chen et al., 2013; Sridharan et al., 2013). Taken together, these observations suggest 
that an open chromatin structure is an optimal starting point for transcription factors to access. 
In chapter I of this study, histone TH2A/TH2B induce an open chromatin structure, which 
would explain their positive effect in reprogramming.  
Indeed many chromatin remodeling factors are important in somatic cell 
reprogramming. For example, the SWI/SNF family, in which esBAF (Brm/Brg associated 
factor) and Ino80 (Inositol requiring 80) promote the binding and activity of OSKM during 
reprogramming (Singhal et al., 2010). In contrast to the remodeling complexes which induce 
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an open chromatin structure, the NuRD (Nucleosome remodeling deacetylase) complex, in 
which Mbd3 is a core subunit contains histone deacetylase activity. Depletion of Mbd3 
significantly enhance the reprogramming efficiency (Rais et al., 2013) through facilitate the 
re-activation of OSKM targets.  
In case of histone variants, histone H3.3 maintains an open chromatin configuration 
by counteract with linker histone H1-mediated chromatin compaction (Braunschweig et al., 
2009). In somatic cell nuclear transfer, histone H3.3 is deposited into somatic donor cell, 
depletion of H3.3 cause failure in reprogramming (Jullien et al., 2012). However, the role of 
H3.3 in reprogramming by OSKM has not been studied. In comparison with TH2A, TH2B 
and H3.3, marco H2A, which possess a unique macro domain and distinct from other 
canonical histones, is shown to associated with heterochromatin.  In ESCs, the level of marco 
H2A is significantly lower than somatic cells, and increasing during the differentiation 
(Creppe et al., 2012). Macro H2A has been shown to be a barrier in reprogramming by 
OSKM. In the absence of macro H2A, iPSC reprogramming efficiency is up 25 fold (Pasque 
et al., 2012). It would be an interesting idea to test the combination of these chromatin 
modifiers and histone variants in reprogramming, because in vivo and in the reprogramming 
by somatic cell nuclear transfer, all of these factors seem to work in concert.  
In earlier report (Shinagawa et al., 2014), we investigated the role of mouse TH2A, 
TH2B and P-Npm2 in reprogramming of MEFs. TH2A, TH2B and P-Npm2 enhanced 
OSKM dependent iPSC generation by produced iPSCs with Oct4 and Klf4. The enhancement 
of TH2A, TH2B and P-Npm2 in mouse system is more than 20 folds, which is significantly 
higher than human system. One of the reason is that the starting materials are different in 
term of developmental age. Mouse embryonic fibroblasts are collected at E13.5, while human 
cell source is later in development (HUVECs, adult and neonatal dermal fibroblasts). During 
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the development, the genome and epigenome are further modified, which could lead to a 
difficulty in erasing and reestablishment.  
iPSCs have a memory and they tend to differentiate to origin cell type. During the 
reprogramming process, the epigenome of somatic cells is erased and established again. In 
contrast to high level of DNA methylation in somatic cells, DNA methylation in the naïve 
stem cells are much lower. The relationship between a faithful transcriptome and DNA 
methylome are demonstrated recently (Ma et al., 2014) by using the same starting material 
for both reprogramming methods: transcription factors induced and somatic cell nuclear 
transfer.  Interestingly, a strong correlation between incomplete reactivation of gene 
expression during reprogramming and high promoter methylation in iPSCs. These 
observation suggests DNA methylation might be responsible for the memory of iPSCs, which 
cause them to easily differentiate into original cell type.  
 In theory, iPSCs are ideal for regenerative medicine and disease modelling. 
Compared to ESCs, iPSCs can be derived from patients, therefore their uses would not be 
hindered by ethical issues. However, many groups have reported that in the mouse system, 
iPSCs are not uniform in their differentiation capacity compared to ESCs. Some iPSC lines 
can differentiate into three germ layers in vitro but fail to contribute to the embryo. Tetraploid 
complementation is a more stringent assay compared to traditional chimera assay, in which 
some iPSC lines can contribute to chimeras but fail to generate embryo in tetraploid assay. 
These observations suggest a significant variation in the quality of iPSCs in mice. 
Furthermore, many mouse rigorous functional assays such as chimera contribution, tetraploid 
complementation are not applicable with human iPSCs. In this study, iPSCs are induced from 
adult dermal fibroblasts, therefore epithelial-like structures, which are representive of 
endodermal lineage, are a good indicator of the differentiated capacity of iPSCs.  Moreover, 
Ware et al., 2014 showed the naïve stem cells have a robust contribution to endodermal 
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lineage compared to prime stem cells. In order to assess the naïve stem cells in vivo, these 
cells should be injected into ICM or early blastocysts and monitor the contribution to the 
embryo. However, regarding the ethic and scarcity of human embryos, teratoma assay is still 
a gold standard in current situation. Since one of human iPSCs application aspect is drug 
screening. In this context, iPSCs need to be differentiated into desired cell types in vitro. A 
high quality iPSCs should be easily differentiated into any lineages with high efficiency.  In 
vitro differentiation assay into specific cell type should be used to assess the capacity of 
human iPSCs generated by OSKMBAN. 
Generally exogenous gene expression is desired to be silenced in human ESC/iPSCs. 
Exogenous SOX2 expression driven by EF1 promoter is still retained. On the other hand, 
exogenous c-MYC expression driven by CMV promoter is suppressed in spite of delivering 
by the lentiviral vector. In agreement with these observations, Xia et al. (2007) reported that 
expression of gene delivered by lentiviral vector in human ESCs is depend on promoter. 
CMV promoter is highly suppressed while EF1 promoter is not affected in human embryonic 
stem cells. Therefore human OSKMBAN iPSCs are similar to human ESCs in the context of 
transgene promoter silencing, which exhibit high suppression of CMV promoter.  
The effect of BAN is depend on the cell type of origin. BAN can enhance the number 
of TRA-1-60 and SSEA-4 positive colony number in HUVECs about 8 fold and 3.5 fold 
respectively. On the other hand, the degree of enhancement for adult dermal fibroblast is 
approximately 2.5 fold. It is reported that HUVECs can be reprogrammed with high 
efficiency and faster kinetic compared to adult fibroblast (Panopoulos et al., 2011). In 
agreement which Panopoulos et al., when using HUVECs, SSEA-4 positive colony can be 
detected as early as 10 days post infection. During the reprogramming process, chromatin is 
reorganized and open chromatin structure is formed. HUVECs may efficiently form open 
chromatin than adult fibroblasts. Therefore BAN maybe more easily incooperated into 
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chromatin of HUVECs than adult fibroblasts, thus the effect of BAN in reprogramming of 
HUVECs is more prominent compared to adult fibroblasts.  
When BAN is expressed prior to OSKM induction, the efficiency of reprogramming 
in more augmented. This observation suggest that histone TH2A and TH2B need to be 
incorporated at a relative high level into the chromatin prior the present of OSKM. After 
several DNA replications and cell divisions, TH2A and TH2B can prepare a permissive 
chromatin structure which may promote the binding of OSKM into their targets site. Indeed, 
DNA synthesis is a pre-requisite for reprogramming by somatic cell fusion (Tsubouchi et al., 
2013). One speculation is that during the DNA replication, the existing chromatin structure is 
disrupted and reestablished and incorporation of histone variants occur.  
In mouse system, we found that TH2A and TH2B are enriched on the X chromosome 
compared with autosomes during the reprogramming (Shinagawa et al., 2014). Furthermore 
the iPSC generation using TH2A and TH2B is enhanced when using Xist  knockout MEFs. 
Inoue et al. (2010) reported that the cloning efficiency of both male and female cells by 
somatic cell nuclear transfer is increased by Xist deletion. This finding suggests that changes 
in the chromatin structure of the X chromosome affect the reprogramming process, although 
the mechanism is unknown. These results suggest that the mechanism of reprogramming 
using TH2A and TH2B in combination with OSKM is more closely linked to reprogramming 
by somatic cell nuclear transfer, in addition TH2A and TH2B also play a functional role in 
reprogramming by somatic cell nuclear transfer. TH2A and TH2B enhanced the OSKM 
reprogramming in both female and male MEFs, suggesting that TH2A and TH2B action 
mechanism is not likely to be associated with the reactivation of inactive X chromosome. On 
both the X chromosome and autosomes, TH2A and TH2B are distributed uniformly, which is 
consistent with a recent report showing that TH2B is not enriched at specific loci in 
spermatocytes and spermatids (Montellier et al., 2013). Therefore TH2A and TH2B facilitate 
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reprogramming by changing the whole chromatin structure rather than by regulating the 
expression of specific genes.  
Comparison between OSKM and OSKM induced iPSCs, TH2A and TH2B regulated 
genes are overlapped with transcript signature of naïve human ESCs. Recently many reports 
have shown that human pluripotent stem cells can be toggled back and forth between two 
states “naïve” and “prime” (Chan et al., 2013; Gafni et al., 2013; Takashima et al., 2014; 
Theunissen et al., 2014; Ware et al., 2014). Naïve state cells are showed to have a high 
cellular potency due to the genome wide low methylation levels (Takashima et al., 2014; 
Theunissen et al., 2014) and low expression of lineage specific genes (Theunissen et al., 
2014).  These naïve stem cells are closely resemble to the early blastocyst stage while the 
prime stem cells resemble post implantation stage. In mice, TH2A and TH2B are highly 
deposited into X chromosome (Shinagawa et al., 2014). However these naïve genes are not 
enriched in X chromosome, which indicate the activation of these genes is a secondary effect.  
Until now mechanisms underlie the naïve state is still unclear and how TH2A and TH2B 
involve in this naïve state is an interesting topic for further research.   
Stella/DPPA3/PGC7 is a good marker for high quality iPSCs. Recently many groups 
have reported the existence of naïve stem cells, which possess high quality compared to 
prime stem cells. These reports differ in medium and factors used for induction of naïve stem 
cells, which make the mechanism lying this phenomena seems obscured. However, most of 
the global gene expression data indicated that Stella/DPPA3/PGC7 is upregulated in all the 
naïve stem cell lines compared to prime stem cells. Including current study, which TH2A and 
TH2B also upregulated Stella/DPPA3/PGC7, this gene may be a good marker for high 
quality iPSCs. Interestingly, Stella is highly expressed in oocyte and the expression gradually 
reduce until ICM stage. In reprogramming process by OSKM, Stella/DPPA3/PGC7 is the last 
gene which is only expressed by fully reprogrammed cells in the stabilization stage.  
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The pathway analysis categorized BAN-upregulated genes in glycolysis and 
gluconeogenesis. Interestingly, naïve cells favor glycolysis while differentiated cells rely on 
oxidation. Glycolysis provides acetyl-CoA for maintaining the histone acetylation and 
blocking the glycolysis forces the cells into differentiation (Panopoulos et al., 2012; 
Moussaieff et al., 2015). Taken together, these suggest that TH2A, TH2B, and P-NPM2 
induce metabolic changes from oxidation to glycolysis, resulted in high cellular potency.   
BAN-upregulated genes are also enriched in Jak-Stat signaling pathway. This 
pathway and pluripotency network have been well studied. Stat3 is an important protein 
which links the LIF-signal into the pluripotent gene network. Stat3 is a transcription factor 
after translocating into the nuclei. It has been reported that Klf4 is a direct target of Stat3, 
while many other transcription factors are regulated by Stat3 such as Zfp57, Tfcp2l1 and 
Gbx2.  Moreover the naïve state specific genes include Klf2, Klf4, Klf5, Tbx3, Esrrb and 
Nr0b1 are known as transcription factors which are downstream of LIF (Ohtsuka et al., 2015).  
Chen et al. recently reported that reinforcement of Stat3 in human ESCs can promote them 
into a naïve stem cell state.  
In summary, histone TH2A, TH2B and P-NPM2 enhance the reprogramming in 
human cells and improve the quality of iPSCs. This study indicate that addition of TH2A, 
TH2B and P-NPM2 in the reprogramming cocktail may be a useful tool for generating 
clinical grade iPSCs effectively. 
There are two major methods for reprogramming a somatic nucleus: somatic cell 
nuclear transfer and ectopic expression of embryonic enriched transcription factors. These 
two methods differ in their technical difficulty, efficiency of reprogramming, kinetic of 
reprogramming. In this study, the use of oocyte enriched factors facilitate the reprogramming 
by embryonic enriched transcription factors. However, one of the most intriguing questions in 
46 
 
this field is the kinetic of reprogramming by oocyte is only two to three days while retaining 
an intact genome and result in faithful totipotent/pluripotent cells. Histone TH2A and TH2B 
seem to be one of those key players in oocyte reprogramming. Screening of other oocyte 
enriched factors may be the answer for this question.   
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Figure legends 
Figure 1.1 Developmental process and cellular potency. As the development progresses, 
cellular potency reduces. Mouse ESCs and human naïve ESCs are closely related to ICM, 
while epiblast stem cells and human primed ESCs are closed to the post-implantation epiblast 
stage. 
 
Figure 1.2 Developmental Expression of Histone TH2A and TH2B (Shinagawa et al., 
2014) (A) The average levels of Th2a and Th2b mRNA in various tissues and cells relative to 
the levels in MEFs are shown ±SD (n = 3). (B) Immunofluorescence images of TH2A/TH2B 
(red) or Oct3/4 (green) stained oocytes and early embryos. DNA was visualized with DAPI 
(blue). Regions marked by white squares are shown at a higher magnification. m, male 
pronucleus; f, female pronucleus; PB, polar body. Scale bars, 50 μm. 
 
Figure 1.3 The efficiency of reprogramming by TH2A, TH2B and P-NPM2. (Shinagawa 
et al., 2014) Nanog-GFP MEFs (male) were infected with retroviruses to express the 
indicated factors, and the percentage of GFP+ cells was analyzed using FACS on day 10 
postinfection The mean is indicated by a green bar. Exp., experiment.  
 
Figure 1.4 Summary of TH2A/TH2B enhancing iPSC generation in mouse MEFs 
(Shingawa et al., 2014).  
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Figure 2.1 Expression and deposition of TH2A/TH2B into chromatin. Using NIH3T3 
cells expressing TH2A/TH2B and P-Npm or H2A/H2B and P-Npm, or containing control 
empty vector, the expression levels (a) and deposition into chromatin (b) of the indicated 
histones were examined.  
 
Figure 2.2 Increase in DNase I sensitivity induced by TH2A/TH2B. Nuclei prepared from 
NIH3T3 cells expressing the indicated proteins were incubated with DNase I for the indicated 
time, and the average amount of digested DNA is shown ± SD (n = 3).  
 
Figure 2.3 MNase sensitivity was not affected by TH2A/TH2B. Nuclei were prepared 
from two types of NIH3T3 cells expressing the empty vectors, TH2A/TH2B and P-Npm, or 
H2A/H2B and P-Npm. Nuclei were treated with various amounts of MNase, and the digested 
DNA was analyzed by agarose gel electrophoresis.  
 
Figure 2.4 The total amount of histone H3K9me3 was not affected by TH2A/TH2B. 
(Left panel) Using ELISA, the amount of histone H3K9me3 was measured using various 
amounts of the histone fraction (R-squared = 0.96). (Right panel) The amount of histone 
H3K9me3 was measured using a chromatin fraction prepared from NIH3T3 cells expressing 
TH2A/TH2B/P-Npm or H2A/H2B/P-Npm, or one prepared from cells infected with empty 
vector. For the positive and negative controls, chromatin fractions enriched in tight  
heterochromatin (inactive chromatin) or enriched in euchromatin (active chromatin) were 
used. The relative average level of H3K9me3 compared with that of control NIH3T3 cells is 
shown ± SD (n = 3). N.S., no significant difference.  
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Figure 2.5 Histone H3K9me3 signals were not affected by TH2A/TH2B. NIH3T3 cells 
expressing TH2A/TH2B/P-Npm or H2A/H2B/P-Npm were immunostained with anti-
H3K9me3 (red) or anti-TH2B (green). DNA was stained with TO-PRO-3. The image 
surrounded by a white box is shown at a higher magnification. The merged images are shown 
in the panels at the right. 
 
Figure 2.6 Defects in histone replacement during spermiogenesis in Th2a-/-Th2b-/- mice. 
(A) Testis sections were immunostained with anti-TNP2 (green) and anti-γH2AX (red) 
antibodies.  The stage of the seminiferous epithelial cycle was judged by the morphology of 
spermatids and the staining pattern of γH2AX. (B) Representative immunostaining images of 
spermatids are shown. The abnormal nuclear morphology is marked by blue triangles. (C) 
Spermatid lysates were separated by centrifugation into supernatant (non-chromatin) and pellet 
(chromatin) fractions, and were used for western blotting. 
 
Figure 2.7 Comparison of mRNA levels of genes that are typically transcribed in 
spermatids in wild-type (+/+) and mutant (-/-) testes. The mRNA levels are shown as an 
average of three measurements (± SD (n = 3)). N.S., not significant.  
 
Figure 2.8 Levels of canonical and variant histones of H2A and H2B in spermatids. 
Round and elongating spermatids were isolated from wild-type and mutant testes, and whole 
cell lysates were used for western blotting. A three-fold serial dilution of proteins was used 
for H2A, while a two-fold serial dilution of proteins was used for the others. 
 
Figure 3.1 Gene structure and amino acid sequences of human histone variants TH2A 
and TH2B. (Upper) Structure of human TH2A and TH2B genes. The direction of 
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transcription is shown by arrow, and the putative binding sites for transcription factors are 
indicated. (Lower) Amino acid sequences of canonical histone H2A (NP_066390.1), H2B 
(NP_003509.1) and histone variants TH2A (NP_734466.1), TH2B (NP_733759.1) were 
aligned. Different amino acids are shown in red color. 
 
Figure 3.2 TH2A and TH2B and histone chaperone P-NPM2 enhanced human iPSC 
generation from human umbilical vein endothelial cells. (A)The number of TRA-1-60-
positivecolonies induced by OSKM or OSKM plus TH2A/TH2B/P-NPM2 (OSKMBAN). 
Human umbilical vein endothelial cells (HUVECs) were infected with lentiviruses to express 
indicated proteins, and stained with anti-TRA-1-60 antibody at day 11 post infection (n=3, 
mean ± SD). Immunostaining of a colony induced by OSKMBAN were shown in the right 
panel. (B)Representative alkaline phosphatase staining of colonies at day 16 post infection. 
(C)The number of SSEA4-positive colony from HUVECs induced by OSKM or OSKMBAN 
at day 11post infection (n=4, mean ± SD).  
 
Figure 3.3 TH2A and TH2B and histone chaperone P-NPM2 enhanced human iPSC 
generation from human fibroblasts. (A) The number of SSEA4-positive colony from adult 
human dermal fibroblasts (HDFs) induced by OSKM or OSKMBAN at day 16 post infection 
(n=4, mean ± SD).  
(B) The number of SSEA4-positive colony from neonatal human dermal fibroblasts (nHDFs) 
induced by OSKM or OSKMBAN at day 16 post infection (n=3, mean ± SD).   
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Figure 3.4 Prolong expression of BAN further enhance reprogramming Adult HDFs 
were infected with virus to express BAN or empty vector 5 days before infection with OSKM 
viruses. The number of SSEA4-positive colony at day 16 post OSKM virus infection is 
shown (n = 3, mean ± SD). 
 
Figure 3.5 Immunofluorescence staining of pluripotency markers in iPSCs from HDFs 
generated by OSKMBAN. iPSCs are stained with anti-NANOG (red) and anti-OCT4 
(green) antibodies, and DAPI (blue).  
 
Figure 3.6 Cell proliferation rate of OSKM, OSKMBAN, BAN and empty vector 
overexpressing human fibroblasts was monitored at indicated days.* indicates p-value ≤ 
0.05, ** indicates p-value ≤ 0.001. 
 
Figure 3.7 In vitro differentiation of iPSCs. OSKMBAN-induced iPSCs were cultured in 
differentiation medium. Immunostaining of beta-III tubulin (TUJ1) for ectoderm, smooth 
muscle actin (SMA) for mesoderm, and alpha-fetoprotein (AFP) for endoderm are 
shown.Scale bar: 100µm. 
 
Figure 3.8 Timing and size of teratoma generated from individual iPSC clones. Grade 0: 
no teratoma, Grade 1: <0.5 cm3, Grade 2: >0.5 cm3.  
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Figure 3.9 In vivo differentiation of iPSCs. (Upper) Hematoxylin and eosin staining of 
teratoma sections. OSKMBAN-induced iPSCs generated well-differentiated teratomas 
containing all three germ layers. Typical morphologies of chondrocyte (mesoderm), neural 
rosette (ectoderm), and epithelial-like structure (endoderm) are shown. Scale bar: 100µm. 
(Lower) Teratomas were positive for differentiation markers for three germ layers: SMA, 
TUJ1, and AFP. Scale bar: 100µm.  
 
Figure 3.10 OSKMBAN-induced iPSCs showed higher differentiation capacity than 
OSKM-induced iPSCs The size of area of epithelial-like structure in each three OSKM- and 
OSKMBAN-teratomas was measured as in (A), and shown in the boxplot (B and C). Total 
number of the area of epithelial-like structures analyzed in OSKM- and OSKMBAN-
teratomas are 320 and 318, respectively. Middle lines in the box indicates medians; top and 
bottom edges, the lower and upper quartiles (25% and 75%); and whiskers, minimum and 
maximum values; circles are outline values. ** indicates p-value < 0.001.  
 
Figure 3.11 Global gene expression profile of OSKMBAN-induced iPSCs are clustered 
with OSKM-induced iPSCs and human ESCs. Hierarchical cluster analysis of microarray 
expression data from three ES cell lines, each of three clones of OSKM-induced iPSCs and 
OSKMBAN-induced iPSCs, and three fibroblasts. Microarray data for human ESCs and 
human fibroblasts were obtained from Ohi et al. (2011). 
 
71 
 
Figure 3.12 Scatterplots of global gene expression patterns, comparing the indicated 
types of cells (average expression of three clones). The expression levels of some pluripotent 
markers (OCT4, SOX2, NANOG, ZFP42, and GDF3) are shown in red. 
 
Figure 3.13 Expression of endogenous OCT4, NANOG, and GDF3 mRNAs in 
OSKMBAN-induced iPSCs was compared to that in OSKM-induced iPSCs or HDFs. 
Data shown as mean ± SD (n = 3). NS indicates no significant different.  
 
Figure 3.14 Exogenous expression of cMYC and SOX2 in human iPSC clones. (Upper 
panel) Exogeneous cMYC expression and (Lower panel) exogenous SOX2 expression were 
measured by qRT-PCR and normalized to GAPDH, n = 3. Expression at 4 days post infection 
was used as control.   
 
Figure 3.15 Gene set enrichment analysis of OSKM- and OSKMBAN-induced iPSCs. 
Up-regulated genes in OSKMBAN-induced iPSCs compared to OSKM-induced iPSCs are 
shown (q value <0.1).  
 
Figure 3.16 GSEA analysis for OSKMBAN- and OSKM-induced iPSCs probe sets with 
up- and down-regulated transcripts of naïve pluripotent stem cells compared to primed 
pluripotent stem cells. Four fold up- or down-regulated transcripts were retrieved from 
Theunissen et al. (2014).   
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